{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:04:34Z","timestamp":1793037874666,"version":"4.5.0"},"reference-count":295,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The adaptation of the uterine circulation during pregnancy is fundamental to ensure an adequate supply of oxygen and nutrients to the fetus, and this process is largely orchestrated by placental hormones\/metabolites. In this review, we comprehensively examine the role of placental hormones, growth factors, and proteins in mediating vascular remodeling, vasodilation, and angiogenesis within the uterine circulation under both physiological and pathological conditions. Key molecules such as estrogens, progesterone, relaxin, VEGF, PlGF, and PTHrP, among others, promote structural and functional adaptations of uterine arteries, reduce vascular resistance, and enhance uteroplacental blood flow. Additionally, we discuss the impact of placental dysfunction on the development of pregnancy-related disorders such as preeclampsia, intrauterine growth restriction, gestational diabetes mellitus, and placenta accreta spectrum conditions that share common features of impaired uterine vascular remodeling and altered placental secretome. Furthermore, we explore innovative therapeutic strategies that aim to restore placental and vascular function, including gene therapy, mesenchymal stem cell-based approaches, and targeted nanomedicine. Finally, we highlight the emerging role of placental biomarkers for early diagnosis and risk stratification of vascular complications in pregnancy. Understanding the intricate interplay between placental secretions and the maternal vasculature is critical to advancing the prevention, diagnosis, and treatment of pregnancy complications, ultimately improving maternal and fetal health outcomes.<\/jats:p>","DOI":"10.3389\/fendo.2025.1637570","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T04:10:25Z","timestamp":1755576625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of placental hormones and metabolites in modulating uterine circulation in physiological and pathological pregnancies"],"prefix":"10.3389","volume":"16","author":[{"given":"Milena","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Paulesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mandal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1152\/physiol.00033.2008","article-title":"Maternal uterine vascular remodeling during pregnancy","volume":"24","author":"Osol","year":"2009","journal-title":"Physiology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/plac.1999.0513","article-title":"Placental oxygen consumption. Part I: in vivo studies\u2013a review","author":"Carter","year":"2000","journal-title":"Placenta"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.mcp.2024.101953","article-title":"Reference data on estrogen metabolome in healthy pregnancy","volume":"74","author":"Karvaly","year":"2024","journal-title":"Mol Cell Probes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.3.755","article-title":"Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model","volume":"91","author":"Morales","year":"1995","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.146399","article-title":"Estradiol-17beta and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites stimulate proliferation in uterine artery endothelial cells: role of estrogen receptor-alpha versus estrogen receptor-beta","volume":"55","author":"Jobe","year":"2010","journal-title":"Hypertension"},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2010.06.020","article-title":"Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA\/ROCK pathway","volume":"335","author":"Oviedo","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04211.x","article-title":"Estrogens and the vascular endothelium","volume":"966","author":"Cid","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"109092","DOI":"10.1016\/j.biopha.2019.109092","article-title":"Estradiol promotes trophoblast viability and invasion by activating SGK1","volume":"117","author":"He","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2005.04.005","article-title":"Suppression of extravillous trophoblast invasion of uterine spiral arteries by estrogen during early baboon pregnancy","volume":"27","author":"Albrecht","year":"2006","journal-title":"Placenta"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.030","article-title":"EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone","volume":"86","author":"Dang","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0116","article-title":"Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy","volume":"149","author":"Bonagura","year":"2008","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.105910","article-title":"Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat","volume":"183","author":"Storment","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00736.2007","article-title":"Vasorelaxant action of 17 -estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors","volume":"293","author":"Scott","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gat095","article-title":"Human uterine and placental arteries exhibit tissue-specific acute responses to 17\u03b2-estradiol and estrogen-receptor-specific agonists","volume":"20","author":"Corcoran","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115996","article-title":"G-protein-coupled estrogen receptor expression in rat uterine artery is increased by pregnancy and induces dilation in a Ca2+ and ERK1\/2 dependent manner","volume":"23","author":"Tropea","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(02)00135-0","article-title":"Mechanisms modulating estrogen-induced uterine vasodilation","volume":"38","author":"Rosenfeld","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124349","article-title":"Estrogen receptors and estrogen-induced uterine vasodilation in pregnancy","volume":"21","author":"Bai","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1055\/s-0031-1299597","article-title":"Estrogen receptor-\u03b1 and estrogen receptor-\u03b2 in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow","volume":"30","author":"Pastore","year":"2012","journal-title":"Semin Reprod Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0141997","DOI":"10.1371\/journal.pone.0141997","article-title":"Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway","volume":"10","author":"Tropea","year":"2015","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072592","article-title":"Influence of estrogens on uterine vascular adaptation in normal and preeclamptic pregnancies","volume":"21","author":"Mandal\u00e0","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-11-1-124","article-title":"Placental steroid hormone biosynthesis in primate pregnancy","volume":"11","author":"Albrecht","year":"1990","journal-title":"Endocr Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.07.009","article-title":"Strong variation in progesterone production of the placenta in early pregnancy - what are the clinical implications","volume":"41","author":"Neumann","year":"2020","journal-title":"Reprod BioMed Online"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aogs.12771","article-title":"Physiology, production and action of progesterone","author":"Taraborrelli","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.280.4.H1699","article-title":"Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS","volume":"280","author":"Rupnow","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh803","article-title":"Progestogens stimulate prostacyclin production by human endothelial cells","volume":"20","author":"Hermenegildo","year":"2005","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod66.2.468","article-title":"Endothelial vasodilator production by uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1, and PGIS protein expression1","volume":"66","author":"Rupnow","year":"2002","journal-title":"Biol Reprod"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.130781","article-title":"Direct chronic effect of steroid hormones in attenuating uterine arterial myogenic tone: role of protein kinase c\/extracellular signal-regulated kinase 1\/2","volume":"54","author":"Xiao","year":"2009","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semnephrol.2010.10.003","article-title":"Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia","volume":"31","author":"Conrad","year":"2011","journal-title":"Semin Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12958-016-0148-y","article-title":"Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantation","volume":"14","author":"Marshall","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2000.00361.x","article-title":"Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites","volume":"8","author":"Unemori","year":"2000","journal-title":"Wound Repair Regener"},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1095\/biolreprod.114.127209","article-title":"Conditional deletion of the relaxin receptor gene in cells of smooth muscle lineage affects lower reproductive tract in pregnant mice","volume":"92","author":"Kaftanovskaya","year":"2015","journal-title":"Biol Reprod"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.113.108118","article-title":"Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment","volume":"89","author":"Gooi","year":"2013","journal-title":"Biol Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-210567","article-title":"Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow","volume":"26","author":"Vodstrcil","year":"2012","journal-title":"FASEB J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.454","article-title":"Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro","volume":"188","author":"Longo","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1126","article-title":"Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide","volume":"152","author":"McGuane","year":"2011","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0567","article-title":"Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats","volume":"147","author":"Debrah","year":"2006","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.4.1057","article-title":"A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy","volume":"13","author":"Evans","year":"1998","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.6.1619","article-title":"Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth","volume":"14","author":"Wheeler","year":"1999","journal-title":"Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.09.016","article-title":"Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy","volume":"34","author":"Zamudio","year":"2013","journal-title":"Placenta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod48.5.1120","article-title":"Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines","volume":"48","author":"Charnock-Jones","year":"1993","journal-title":". Biol Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(05)80424-2","article-title":"Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts","volume":"15","author":"Anthony","year":"1994","journal-title":"Placenta"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/endo.133.2.8344219","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth","volume":"133","author":"Cullinan-Bove","year":"1993","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/10623320590933879","article-title":"Uterine venous permeability in the rat is altered in response to pregnancy, vascular endothelial growth factor, and venous constriction","volume":"12","author":"Celia","year":"2005","journal-title":"Endothelium"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.108.6.2369","article-title":"Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor","volume":"108","author":"Roberts","year":"1995","journal-title":"J Cell Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(91)91276-I","article-title":"Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells","volume":"181","author":"Pepper","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041530317","article-title":"Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells","volume":"153","author":"Unemori","year":"1992","journal-title":"J Cell Physiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00437","article-title":"Pregnancy augments VEGF-stimulated in vitro angiogenesis and vasodilator (NO and H2S) production in human uterine artery endothelial cells","volume":"102","author":"Zhang","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0014-5793(97)01481-6","article-title":"Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42\/p44 mitogen-activated protein kinase","volume":"420","author":"Wheeler-Jones","year":"1997","journal-title":"FEBS Lett"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.102","article-title":"Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep","volume":"15","author":"David","year":"2008","journal-title":"Gene Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.158","article-title":"Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep","volume":"19","author":"Mehta","year":"2012","journal-title":"Gene Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100021","article-title":"Local over-expression of VEGF-D\u0394N\u0394C in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis","volume":"9","author":"Mehta","year":"2014","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.2.H938","article-title":"Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects","volume":"273","author":"Ni","year":"1997","journal-title":"Am J Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2013.01.004","article-title":"Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia","volume":"3","author":"Saffer","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod56.2.489","article-title":"Expression of vascular endothelial growth factor and placenta growth factor in human placenta","volume":"56","author":"Vuorela","year":"1997","journal-title":"Biol Reprod"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.01.012","article-title":"Correlations of placental perfusion and PlGF protein expression in early human pregnancy","volume":"194","author":"Welch","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4267","article-title":"Genetic deletion of placenta growth factor in mice alters uterine NK cells","volume":"178","author":"Tayade","year":"2007","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1159\/000082622","article-title":"Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy","volume":"59","author":"Szukiewicz","year":"2005","journal-title":"Gynecologic Obstetric Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00922.2007","article-title":"Placental growth factor is a potent vasodilator of rat and human resistance arteries","volume":"294","author":"Osol","year":"2008","journal-title":"Am J Physiology-Heart Circulatory Physiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0143-4004(98)90020-0","article-title":"Intrauterine expression of parathyroid hormone-related protein in normal and pre-eclamptic pregnancies","volume":"19","author":"Curtis","year":"1998","journal-title":"Placenta"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138306","article-title":"Parathyroid hormone related protein (PTHrP) gene expression in fetal and extra-embryonic tissues of early pregnancy","volume":"9","author":"Dunne","year":"1994","journal-title":"Hum Reprod"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsgi.2004.07.005","article-title":"Parathyroid hormone-related protein-induced relaxation of rat uterine arteries: influence of the endothelium during gestation","volume":"12","author":"Meziani","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4004(77)90014-5","article-title":"Vascular effects of PTHrP (1-34) and PTH (1-34) in the human fetal-placental circulation","volume":"18","author":"Macgill","year":"1997","journal-title":"Placenta"},{"key":"B68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/107155769400100105","article-title":"Vasodilator effects of parathyroid hormone, parathyroid hormone-related protein, and calcitonin gene-related peptide in the human fetal-placental circulation","volume":"1","author":"Mandsager","year":"1994","journal-title":"J Soc Gynecol Investig"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm269","article-title":"Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways","volume":"22","author":"Rashid","year":"2007","journal-title":"Nephrol Dialysis Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0568","article-title":"Expression and biological activity of parathyroid hormone-related peptide in pregnant rat uterine artery: any role for 8-iso-prostaglandin F2\u03b1","volume":"149","author":"Meziani","year":"2008","journal-title":"Endocrinology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.placenta.2003.08.001","article-title":"PTH\/PTHrP receptor and mid-molecule PTHrP regulation of intrauterine PTHrP: PTH\/PTHrP receptor antagonism increases SHR fetal weight","volume":"25","author":"Wlodek","year":"2004","journal-title":"Placenta"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.7.8675597","article-title":"The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface","volume":"81","author":"Han","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030243","article-title":"Possible angiogenic roles of insulin-like growth factor II and its receptors in uterine vascular adaptation to pregnancy","volume":"88","author":"Herr","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/345078a0","article-title":"A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting","volume":"345","author":"DeChiara","year":"1990","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/43.12.2323","article-title":"Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A\/proeosinophil major basic protein (PAPP-A\/proMBP) complex in first-trimester maternal serum screening for Down syndrome","volume":"43","author":"Qin","year":"1997","journal-title":"Clin Chem"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2016.04.015","article-title":"PAPP-A and the IGF system","volume":"77","author":"Monget","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.5152\/jtgga.2016.16040","article-title":"Predictive values of maternal serum PAPP-A level, uterine artery Doppler velocimetry, and fetal biometric measurements for poor pregnancy and poor neonatal outcomes in pregnant women","volume":"17","author":"Balc\u0131","year":"2016","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.2.1379262","article-title":"The expression of human chorionic gonadotropin\/luteinizing hormone receptors in human endometrial and myometrial blood vessels","volume":"75","author":"Lei","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.1.8027246","article-title":"Expression of functional human chorionic gonadotropin\/human luteinizing hormone receptor gene in human uterine arteries","volume":"79","author":"Toth","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020642","article-title":"Characterization of human chorionic gonadotropin as a novel angiogenic factor","volume":"87","author":"Zygmunt","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.12.2515","article-title":"Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization","volume":"16","author":"Wulff","year":"2001","journal-title":"Hum Reprod"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1282","article-title":"Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling","volume":"149","author":"Prast","year":"2008","journal-title":"Endocrinology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s004249900151","article-title":"Human chorionic gonadotropin dilates uterine and mesenteric resistance arteries in pregnant and nonpregnant rats","volume":"439","author":"Hermsteiner","year":"1999","journal-title":"Pfl\u00fcgers Archiv"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00145","article-title":"Placental protein 13 (Galectin-13) polarizes neutrophils toward an immune regulatory phenotype","volume":"11","author":"Vokalova","year":"2020","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1933719111424445","article-title":"Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia","volume":"19","author":"Kliman","year":"2012","journal-title":"Reprod Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000381914","article-title":"Placental protein 13 administration to pregnant rats lowers blood pressure and augments fetal growth and venous remodeling","volume":"39","author":"Gizurarson","year":"2016","journal-title":"Fetal Diagn Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2017.1295052","article-title":"Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways","volume":"36","author":"Drobnjak","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S188303","article-title":"Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration","volume":"11","author":"Drobnjak","year":"2019","journal-title":"Int J Womens Health"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2022.07.001","article-title":"Placental protein 13 dilation of pregnant rat uterine vein is endothelium dependent and involves nitric oxide\/calcium activated potassium channels signals","volume":"126","author":"Gatto","year":"2022","journal-title":"Placenta"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147522","article-title":"Placental protein 13: vasomodulatory effects on human uterine arteries and potential implications for preeclampsia","volume":"25","author":"Gatto","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0690503","article-title":"Simultaneous determinations of uterine blood flow and plasma concentrations of placental lactogen in late-pregnant goats","volume":"69","author":"Hayden","year":"1983","journal-title":"J Reprod Fertil"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(84)80026-0","article-title":"Relationship of maternal and fetal levels of human placental lactogen to the weight and sex of the fetus","volume":"5","author":"Houghton","year":"1984","journal-title":"Placenta"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00311.2015","article-title":"Development of ovine chorionic somatomammotropin hormone-deficient pregnancies","volume":"310","author":"Baker","year":"2016","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1246","article-title":"Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis","volume":"96","author":"Struman","year":"1999","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1550","article-title":"Stimulation of human trophoblast invasion by placental growth hormone","volume":"146","author":"Lacroix","year":"2005","journal-title":"Endocrinology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1993.265.4.E572","article-title":"Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies","volume":"265","author":"Caufriez","year":"1993","journal-title":"Am J Physiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2010.12.002","article-title":"Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction","volume":"21","author":"Koutsaki","year":"2011","journal-title":"Growth Hormone IGF Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030282","article-title":"A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth","volume":"89","author":"Chellakooty","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nm0997-1029","article-title":"Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans","volume":"3","author":"Masuzaki","year":"1997","journal-title":"Nat Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ng0396-318","article-title":"Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin","volume":"12","author":"Chehab","year":"1996","journal-title":"Nat Genet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.12.8535","article-title":"Leptin requirement for conception, implantation, and gestation in the mouse","volume":"142","author":"Malik","year":"2001","journal-title":"Endocrinology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(98)00299-3","article-title":"Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term","volume":"92","author":"Henson","year":"1998","journal-title":"Obstet Gynecol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1386309","article-title":"The effects of leptin on human cytotrophoblast invasion are gestational age and dose-dependent","volume":"15","author":"Rumer","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.104.032722","article-title":"The effect of leptin on mouse trophoblast cell invasion1","volume":"71","author":"Schulz","year":"2004","journal-title":"Biol Reprod"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/6.10.951","article-title":"Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion","volume":"6","author":"Castellucci","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/iox008","article-title":"Uterine artery leptin receptors during the ovarian cycle and pregnancy regulate angiogenesis in ovine uterine artery endothelial cells\u2020","volume":"96","author":"Vargas","year":"2017","journal-title":"Biol Reprod"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.10.1059","article-title":"Leptin, the product of ob gene, promotes angiogenesis","volume":"83","author":"Bouloumi\u00e9","year":"1998","journal-title":"Circ Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.36.suppl_1.725-a","article-title":"Leptin causes vasodilation in humans","volume":"36","author":"Nakagawa","year":"2000","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-5-1001","article-title":"The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation","volume":"72","author":"Riley","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.2.8045990","article-title":"Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation","volume":"79","author":"Clifton","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)37970-4","article-title":"Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery","volume":"288","author":"Jain","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050167","article-title":"Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation","volume":"168","author":"Bamberger","year":"2006","journal-title":"Am J Pathol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90709-Z","article-title":"Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels","volume":"164","author":"Fried","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/6.4.352","article-title":"Pregnancy is associated with altered response to neuropeptide Y in uterine artery","volume":"6","author":"Jovanovic","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16929","article-title":"Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles","volume":"111","author":"Lee","year":"2003","journal-title":"J Clin Invest"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.21.6.A1213-a","article-title":"Neuropeptide Y (NPY) Y2 receptor (Y2R) mediates dilation in peripheral collateral vessels","volume":"21","author":"Taylor","year":"2007","journal-title":"FASEB J"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1177\/1535370219831437","article-title":"Placental Neuropeptide Y (NPY) and NPY receptors expressions and serum NPY levels in preeclampsia","volume":"244","author":"Klinjampa","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/reprodmed2010005","article-title":"Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1\/PlGF Ratio in the Prediction of Preeclampsia and\/or FGR Near Delivery\u2014A Secondary Analysis","volume":"2","author":"Sharabi-Nov","year":"2021","journal-title":"Reprod Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2316","article-title":"Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis","volume":"78","author":"Singh","year":"2018","journal-title":"Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.3.827","article-title":"Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study","volume":"14","author":"O\u2019Connor","year":"1999","journal-title":"Hum Reprod"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/gye.16.5.365.372","article-title":"Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels","volume":"16","author":"Florio","year":"2002","journal-title":"Gynecological Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/A:1022564722353","article-title":"Expression of inhibin\/activin subunits and their receptors and binding proteins in human preimplantation embryos","volume":"16","author":"He","year":"1999","journal-title":"J Assist Reprod Genet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e21220","DOI":"10.1096\/fj.202001604R","article-title":"Activin A increases human trophoblast invasion by upregulating integrin \u03b21 through ALK4","volume":"35","author":"Zhu","year":"2021","journal-title":"FASEB J"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2022.10.004","article-title":"Activin A promotes human trophoblast invasion by upregulating integrin \u03b23 via ALK4-SMAD4 signaling","volume":"129","author":"Sun","year":"2022","journal-title":"Placenta"},{"key":"B125","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-023-01463-z","article-title":"Fibronectin mediates activin A-promoted human trophoblast migration and acquisition of endothelial-like phenotype","volume":"22","author":"Lan","year":"2024","journal-title":"Cell Communication Signaling"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1228","article-title":"Vascular endothelial growth factor-A (VEGF-A) mediates activin A-induced human trophoblast endothelial-like tube formation","volume":"156","author":"Li","year":"2015","journal-title":"Endocrinology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2016.03.001","article-title":"Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia","volume":"6","author":"Hobson","year":"2016","journal-title":"Pregnancy Hypertension: Int J Women\u2019s Cardiovasc Health"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1530\/REP-21-0368","article-title":"Activin A causes endothelial dysfunction of mouse aorta and human aortic cells","volume":"163","author":"Barber","year":"2022","journal-title":"Reproduction"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1387\/ijdb.130329gd","article-title":"Pregnancy-specific glycoproteins: complex gene families regulating maternal-fetal interactions","volume":"58","author":"Moore","year":"2014","journal-title":"Int J Dev Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2023.06.014","article-title":"Pregnancy-specific beta-1-glycoprotein 1-enriched exosomes are involved in the regulation of vascular endothelial cell function during pregnancy","volume":"139","author":"Jia","year":"2023","journal-title":"Placenta"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061134","article-title":"Pregnancy-specific glycoprotein 9 enhances store-operated calcium entry and nitric oxide release in human umbilical vein endothelial cells","volume":"13","author":"Qin","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B132","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1095\/biolreprod.109.082412","article-title":"Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis1","volume":"83","author":"Ha","year":"2010","journal-title":"Biol Reprod"},{"key":"B133","doi-asserted-by":"publisher","first-page":"F1315","DOI":"10.1152\/ajprenal.00071.2020","article-title":"Preeclampsia beyond pregnancy: long-term consequences for mother and child","volume":"318","author":"Turbeville","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"Subtypes of preeclampsia: recognition and determining clinical usefulness","volume":"77","author":"Roberts","year":"2021","journal-title":"Hypertension"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2024.08.010","article-title":"Prevalence of placental bed spiral artery pathology in preeclampsia and fetal growth restriction: A prospective cohort study","volume":"156","author":"Brouwers","year":"2024","journal-title":"Placenta"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000964","article-title":"Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) study","volume":"34","author":"Veerbeek","year":"2016","journal-title":"J Hypertens"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16276","article-title":"Role of uterine artery doppler ultrasound in predicting pre-eclampsia in high-risk women","volume":"13","author":"Shahid","year":"2021","journal-title":"Cureus"},{"key":"B138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/uog.23623","article-title":"Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19\u201324\u2009weeks\u2019 gestation","volume":"58","author":"Litwinska","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.placenta.2021.01.004","article-title":"Understanding the uterine artery Doppler waveform and its relationship to","volume":"105","author":"Lloyd-Davies","year":"2021","journal-title":"spiral artery remodelling. Placenta"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3109\/10641955.2014.926914","article-title":"Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia","volume":"33","author":"Baltajian","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates","volume":"67","author":"Makris","year":"2016","journal-title":"Hypertension"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99026","article-title":"Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice","volume":"128","author":"Parchem","year":"2018","journal-title":"J Clin Invest"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e5149","DOI":"10.1371\/journal.pone.0005149","article-title":"TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature","volume":"4","author":"Walshe","year":"2009","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2008.02.006","article-title":"Vasculogenesis and angiogenesis in the IUGR placenta","volume":"32","author":"Arroyo","year":"2008","journal-title":"Semin Perinatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1997.tb18405.x","article-title":"Pathophysiology of intrauterine growth retardation: role of the placenta","volume":"423","author":"Pardi","year":"1997","journal-title":"Acta Paediatr Suppl"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2009.83","article-title":"Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension","volume":"29","author":"Srinivas","year":"2009","journal-title":"J Perinatol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.125243","article-title":"Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms","volume":"187","author":"Chen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70103-5","article-title":"Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree","volume":"175","author":"Krebs","year":"1996","journal-title":"Am J Obstetrics Gynecology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1746-1596-5-24","article-title":"Intrauterine growth restriction and placental angiogenesis","volume":"5","author":"Barut","year":"2010","journal-title":"Diagn Pathol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(97)80061-6","article-title":"Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery","volume":"18","author":"Lyall","year":"1997","journal-title":"Placenta"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2016.1219993","article-title":"Placental gene expression of the placental growth factor (PlGF) in intrauterine growth restriction","volume":"30","author":"Jo\u00f3","year":"2017","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1053\/plac.2001.0757","article-title":"Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR)","volume":"23","author":"Regnault","year":"2002","journal-title":"Placenta"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.10.012","article-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline","volume":"103","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B155","doi-asserted-by":"publisher","first-page":"109050","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group\u2019s criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.285","article-title":"Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic review","volume":"4","author":"Mistry","year":"2021","journal-title":"Endocrinology Diabetes Metab"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.3189","article-title":"Risk of adverse pregnancy outcomes among pregnant individuals with gestational diabetes by race and ethnicity in the United States, 2014-2020","volume":"327","author":"Venkatesh","year":"2022","journal-title":"Jama"},{"key":"B158","doi-asserted-by":"publisher","first-page":"165535","DOI":"10.1016\/j.bbadis.2019.165535","article-title":"Placental structure in gestational diabetes mellitus","volume":"1866","author":"Carrasco-Wong","year":"2020","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2011.04.015","article-title":"Stereology of the placenta in type 1 and type 2 diabetes","volume":"32","author":"Higgins","year":"2011","journal-title":"Placenta"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001243","article-title":"Poorly controlled diabetes mellitus alters placental structure, efficiency, and plasticity","volume":"8","author":"Nteeba","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90759-Z","article-title":"Placental thromboxane and prostacyclin production in an ovine diabetic model","volume":"163","author":"Dickinson","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1071\/RD01032","article-title":"Oxidative stress and altered prostanoid production in the placenta of streptozotocin-induced diabetic rats","volume":"14","author":"White","year":"2002","journal-title":"Reprod Fertil Dev"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1080\/08977190802587049","article-title":"The levels of vascular endothelial growth factor-A and placental growth factor-2 in embryopathy associated with experimental diabetic gestation","volume":"27","author":"Salim","year":"2009","journal-title":"Growth Factors"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.69.877","article-title":"Streptozotocin-induced diabetes decreases placenta growth factor (PlGF) levels in rat placenta","volume":"69","author":"Koh","year":"2007","journal-title":"J Vet Med Sci"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/uog.24890","article-title":"Debunking 20th century myths and legends about the diagnosis of placenta accreta spectrum","volume":"59","author":"Jauniaux","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031193","article-title":"Epidemiology of placenta previa accreta: a systematic review and meta-analysis","volume":"9","author":"Jauniaux","year":"2019","journal-title":"BMJ"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000222380.11069.11","article-title":"Maternal complications associated with multiple cesarean deliveries","volume":"108","author":"Nisenblat","year":"2006","journal-title":"Obstet Gynecol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003793","article-title":"Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion","volume":"135","author":"Einerson","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa094","article-title":"Post-Caesarean section niche-related impaired fertility: hypothetical mechanisms","volume":"35","author":"Vissers","year":"2020","journal-title":"Hum Reprod"},{"key":"B170","doi-asserted-by":"publisher","first-page":"443.e1","DOI":"10.1016\/j.ajog.2023.10.001","article-title":"Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium","volume":"230","author":"Afshar","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.10.270","article-title":"105: Decreased expression of endostatin (ES) and hypoxia-inducible factor 1&x3b1; (HIF-1&x3b1); is associated with excessive trophoblast invasion and aberrant angiogenesis in placenta accreta","volume":"208","author":"Duzyj","year":"2013","journal-title":"Am J Obstetrics Gynecology"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15176","article-title":"Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study","volume":"125","author":"Duzyj","year":"2018","journal-title":"Bjog"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.02.038","article-title":"New insights into the etiopathology of placenta accreta","volume":"227","author":"Jauniaux","year":"2022","journal-title":"spectrum. Am J Obstet Gynecol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02597","article-title":"Regulation of placental extravillous trophoblasts by the maternal uterine environment","volume":"9","author":"Pollheimer","year":"2018","journal-title":"Front Immunol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"399.e1","DOI":"10.1016\/j.ajog.2021.08.056","article-title":"Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study","volume":"226","author":"Jauniaux","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00763-4","article-title":"Placenta percreta presents with neoangiogenesis of arteries with von willebrand factor-negative endothelium","volume":"29","author":"Schwickert","year":"2022","journal-title":"Reprod Sci"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(09)60205-9","article-title":"Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta","volume":"45","author":"Tseng","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2021.1955337","article-title":"Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta","volume":"42","author":"Faraji","year":"2022","journal-title":"spectrum. J Obstet Gynaecol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1177\/1933719112472735","article-title":"Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta","volume":"20","author":"Goh","year":"2013","journal-title":"Reprod Sci"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2024.11.008","article-title":"Abnormal placental development induced by repeated cesarean sections: Investigating an animal model of placenta accreta","volume":"158","author":"Ma","year":"2024","journal-title":"Spectr Disord Placenta"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2008.03794.x","article-title":"A randomized, double-blind, placebo-controlled trial of relaxin for cervical ripening in post-delivery date pregnancies","author":"Weiss","year":"1160","journal-title":"Ann N Y Acad Sci 2009"},{"key":"B182","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1692","article-title":"Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis","volume":"22","author":"Teerlink","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"N Engl J Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813730","article-title":"A randomized trial of progesterone in women with bleeding in early pregnancy","volume":"380","author":"Coomarasamy","year":"2019","journal-title":"N Engl J Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17705","article-title":"Vaginal micronised progesterone for the prevention of hypertensive disorders of pregnancy: A systematic review and meta-analysis","volume":"131","author":"Melo","year":"2024","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)56992-1","article-title":"Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial","volume":"62","author":"Quenby","year":"1994","journal-title":"Fertility Sterility"},{"key":"B188","doi-asserted-by":"publisher","first-page":"Cd008611","DOI":"10.1002\/14651858.CD008611.pub2","article-title":"Human chorionic gonadotrophin (hCG) for preventing miscarriage","volume":"2013","author":"Morley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B189","doi-asserted-by":"publisher","first-page":"37498","DOI":"10.52965\/001c.37498","article-title":"Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice","volume":"14","author":"Poliwoda","year":"2022","journal-title":"Orthop Rev (Pavia)"},{"key":"B190","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13287-016-0418-9","article-title":"Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta","volume":"7","author":"Du","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B191","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-024-03652-0","article-title":"Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia","volume":"15","author":"Shi","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2020.07.007","article-title":"Heme oxygenase-1 gene modified human placental mesenchymal stem cells promote placental angiogenesis and spiral artery remodeling by improving the balance of angiogenic factors in vitro","volume":"99","author":"Wu","year":"2020","journal-title":"Placenta"},{"key":"B193","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/scd.2021.0174","article-title":"The protective benefit of heme oxygenase-1 gene-modified human placenta-derived mesenchymal stem cells in a N-nitro-L-arginine methyl ester-induced preeclampsia-like rat model: possible implications for placental angiogenesis","volume":"30","author":"Liu","year":"2021","journal-title":"Stem Cells Dev"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14495","article-title":"Exosomal microRNA-139-5p from mesenchymal stem cells accelerates trophoblast cell invasion and migration by motivation of the ERK\/MMP-2 pathway via downregulation of protein tyrosine phosphatase","volume":"46","author":"Liu","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.06.032","article-title":"Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia","volume":"105","author":"Xiong","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B196","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s40001-023-01182-8","article-title":"Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia","volume":"28","author":"Chang","year":"2023","journal-title":"Eur J Med Res"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","article-title":"Exposure to maternal depression alters the amygdala transcriptome and microglia morphology in the developing offspring","volume":"2","author":"Xu","year":"2022","journal-title":"Lipid Nanoparticles Drug Delivery"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400938","article-title":"Advances in lipid nanoparticle-based disease treatment","volume":"20","author":"Zhou","year":"2025","journal-title":"ChemMedChem"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307810121","article-title":"Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes","volume":"121","author":"Chaudhary","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.2c12893","article-title":"Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy","volume":"145","author":"Swingle","year":"2023","journal-title":"J Am Chem Soc"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2023.11.014","article-title":"Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach","volume":"34","author":"Young","year":"2024","journal-title":"Bioactive Materials"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.02.038","article-title":"Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector","volume":"32","author":"Katayama","year":"2011","journal-title":"Biomaterials"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2013.214","article-title":"Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies","volume":"25","author":"Carr","year":"2014","journal-title":"Hum Gene Ther"},{"key":"B205","doi-asserted-by":"publisher","first-page":"R344","DOI":"10.1152\/ajpregu.00210.2017","article-title":"Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted Guinea pig fetus","volume":"315","author":"Vaughan","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140879","article-title":"Development of non-viral, trophoblast-specific gene delivery for placental therapy","volume":"10","author":"Abd Ellah","year":"2015","journal-title":"PloS One"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1055234","article-title":"Placental treatment with insulin-like growth factor 1 via nanoparticle differentially impacts vascular remodeling factors in Guinea pig sub-placenta\/decidua","volume":"13","author":"Davenport","year":"2022","journal-title":"Front Physiol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.23644","article-title":"Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted Guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations","volume":"89","author":"Wilson","year":"2022","journal-title":"Molecular Reproduction and Development"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2020.02.006","article-title":"Nanoparticle mediated increased insulin-like growth factor 1 expression enhances human placenta syncytium function","volume":"93","author":"Wilson","year":"2020","journal-title":"Placenta"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2017.07.360","article-title":"Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery","volume":"58","author":"Yu","year":"2017","journal-title":"Placenta"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","volume":"36","author":"Turanov","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2017034","article-title":"Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia","volume":"59","author":"Luewan","year":"2018","journal-title":"Singapore Med J"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"Bjog"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.08.006","article-title":"First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia","volume":"34","author":"Keikkala","year":"2013","journal-title":"Placenta"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5206","article-title":"Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester","volume":"31","author":"Leung","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1251","article-title":"Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenat Diagn"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2019.01006","article-title":"Raised neutrophil lymphocyte ratio and serum beta hCG level in early second trimester of pregnancy as predictors for development and severity of preeclampsia","volume":"13","author":"Panwar","year":"2019","journal-title":"Drug Discov Ther"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.619530","article-title":"Predictive performance of serum \u03b2-hCG moM levels for preeclampsia screening: A meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1665","article-title":"First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system","volume":"27","author":"Cowans","year":"2007","journal-title":"Prenat Diagn"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318188d6f9","article-title":"First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome","volume":"112","author":"Poon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1159\/000275669","article-title":"Maternal serum ADAM-12 as a potential marker for different adverse pregnancy outcomes","volume":"27","author":"Matwejew","year":"2010","journal-title":"Fetal Diagn Ther"},{"key":"B223","doi-asserted-by":"publisher","first-page":"122.e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0b013e31824e9a68","article-title":"Placental protein 13 as an early predictor in Egyptian patients with preeclampsia, correlation to risk, and association with outcome","volume":"60","author":"El Sherbiny","year":"2012","journal-title":"J Investig Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.756383","article-title":"Predictive performance of placental protein 13 for screening preeclampsia in the first trimester: A systematic review and meta-analysis","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512051","article-title":"Augmented placental protein 13 in placental-associated extracellular vesicles in term and preterm preeclampsia is further elevated by corticosteroids","volume":"24","author":"Kazatsker","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B227","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/cclm-2017-0356","article-title":"Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia","volume":"56","author":"De Villiers","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.05.024","article-title":"Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women","volume":"25","author":"Keikkala","year":"2021","journal-title":"Pregnancy Hypertension"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.19082\/6186","article-title":"A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women","volume":"10","author":"Broumand","year":"2018","journal-title":"Electron Physician"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2017.11.001","article-title":"Relaxin-2 connecting peptide (pro-RLX2) levels in second trimester serum samples to predict preeclampsia","volume":"11","author":"Rehfeldt","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"B231","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.preghy.2020.07.008","article-title":"Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia","volume":"22","author":"Post Uiterweer","year":"2020","journal-title":"Pregnancy Hypertension"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.33574\/hjog.0504","article-title":"Serum relaxin in preeclamptic and normotensive pregnant women at the Lagos University Teaching Hospital","volume":"21","author":"Ugwu","year":"2022","journal-title":"Hellenic J Obstetrics Gynecology"},{"key":"B233","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00404-014-3303-8","article-title":"Calcitonin gene- and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case\u2013control study","volume":"290","author":"Yadav","year":"2014","journal-title":"Arch Gynecology Obstetrics"},{"key":"B234","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.preghy.2017.12.003","article-title":"The reduction in circulating levels of estrogen and progesterone in women with preeclampsia","volume":"11","author":"Wan","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"B235","doi-asserted-by":"publisher","first-page":"7","DOI":"10.54548\/njps.v38i1.2","article-title":"Serum human placental lactogen assays in ultrasound evaluated pregnancy-induced hypertension: A marker of placental function in pregnancy","volume":"38","author":"Efanga","year":"2023","journal-title":"Niger J Physiol Sci"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03979","article-title":"Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women","volume":"65","author":"Taylor","year":"2015","journal-title":"Hypertension"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.4274\/BMB.galenos.2025.03521","article-title":"Serum leptin as a diagnostic biomarker in preeclampsia: A prospective controlled study","volume":"12","author":"Toplu","year":"2025","journal-title":"Bagcilar Med Bull"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0186","article-title":"The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia","volume":"89","author":"Florio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B239","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0028-2243(91)90136-9","article-title":"Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia","volume":"39","author":"Laatikainen","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2015.09.006","article-title":"Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease","volume":"55","author":"Paiva","year":"2016","journal-title":"Neuropeptides"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.173","article-title":"Maternal serum activin A is not elevated before preeclampsia in women who are at high risk","volume":"188","author":"Blackburn","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1002\/uog.6212","article-title":"Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia","volume":"32","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S512910","article-title":"Investigating serum and placental levels of IGF-1 and IGF-1R in preeclampsia patients and their clinical implications","volume":"17","author":"Su","year":"2025","journal-title":"Int J Womens Health"},{"key":"B244","doi-asserted-by":"publisher","first-page":"e50208","DOI":"10.1371\/journal.pone.0050208","article-title":"Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction","volume":"7","author":"Sibiude","year":"2012","journal-title":"PloS One"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00338-7","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2007.22.5.873","article-title":"Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia","volume":"22","author":"Kim","year":"2007","journal-title":"J Korean Med Sci"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.medici.2016.11.008","article-title":"sFlt-1, PlGF, sFlt-1\/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics","volume":"52","author":"Tarasevi\u010dien\u0117","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"B248","doi-asserted-by":"publisher","first-page":"e31256","DOI":"10.7759\/cureus.31256","article-title":"Importance of low pregnancy associated plasma protein-A (PAPP-A) levels during the first trimester as a predicting factor for adverse pregnancy outcomes: A prospective cohort study of 2636 pregnant women","volume":"14","author":"Papamichail","year":"2022","journal-title":"Cureus"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072502","article-title":"Fetal growth restriction is associated with pregnancy associated plasma protein A and uterine artery doppler in first trimester","volume":"12","author":"Springer","year":"2023","journal-title":"J Clin Med"},{"key":"B250","doi-asserted-by":"publisher","first-page":"8315519","DOI":"10.1155\/2022\/8315519","article-title":"The effect of serum \u03b2-human chorionic gonadotropin on pregnancy complications and adverse pregnancy outcomes: A systematic review and meta-analysis","author":"Huang","year":"2022","journal-title":"Comput Math Methods Med 2022"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.10.533","article-title":"Assessment of first trimester maternal serum placental protein 13 for the prediction of IUGR with and without preeclampsia","volume":"195","author":"Ron","year":"2006","journal-title":"Am J Obstetrics Gynecology - AMER J OBSTET GYNECOL"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1921","article-title":"First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes","volume":"28","author":"Cowans","year":"2008","journal-title":"Prenatal Diagnosis"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.9790\/0853-2006124348","article-title":"Correlation of sonographic fetal growth evaluation with maternal serum Human Placental Lactogen levels","volume":"20","author":"Efanga","year":"2021","journal-title":"IOSR J Dental Med Sci"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1159\/000519609","article-title":"Maternal serum and cord blood leptin concentrations at delivery in normal pregnancies and in pregnancies complicated by intrauterine growth restriction","volume":"15","author":"Stefaniak","year":"2022","journal-title":"Obes Facts"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.06.070","article-title":"Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation","volume":"191","author":"Wadhwa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2468","article-title":"Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction","volume":"98","author":"Whitehead","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B258","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejogrb.2004.02.030","article-title":"Circulating levels of inhibin A, inhibin B and activin A in normal and intrauterine growth restricted (IUGR) fetuses","volume":"117","author":"Morpurgo","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20210068","article-title":"Investigation of serum pregnancy-specific beta-1-glycoprotein and relationship with fetal growth restriction","volume":"26","author":"Tuzluo\u011flu","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2024.05.036","article-title":"The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction","volume":"299","author":"Giorgione","year":"2024","journal-title":"Eur J Obstetrics Gynecology Reprod Biol"},{"key":"B261","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.placenta.2022.07.020","article-title":"Diagnostic capacity of sFlt-1\/PlGF ratio in fetal growth restriction: A systematic review and meta-analysis","volume":"127","author":"Chen","year":"2022","journal-title":"Placenta"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23932","article-title":"OP02.07: sEng versus sFlt-1\/PlGF ratio: prediction of PE, HELLP syndrome and IUGR","volume":"58","author":"Iannaccone","year":"2021","journal-title":"Ultrasound Obstetrics Gynecology"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2774","article-title":"Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction","volume":"92","author":"Stepan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1593362","article-title":"Placental expression of angiogenesis-related genes and their receptors in IUGR pregnancies: correlation with fetoplacental and maternal parameters","volume":"33","author":"Ravikumar","year":"2020","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S316670","article-title":"Altered expression of angiogenic biomarkers in pregnancy associated with gestational diabetes","volume":"14","author":"Al-Ofi","year":"2021","journal-title":"Int J Gen Med"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2011.595852","article-title":"Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women","volume":"25","author":"Laskowska","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12172","article-title":"Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis","volume":"120","author":"Conde-Agudelo","year":"2013","journal-title":"Bjog"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1354-x","article-title":"Plasma levels of relaxin-2 are higher and correlated to C-peptide levels in early gestational diabetes mellitus","volume":"57","author":"Alonso Lopez","year":"2017","journal-title":"Endocrine"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.35.P377","article-title":"Assessment of relaxin levels in pregnant women with gestational diabetes mellitus","volume":"17","author":"Zaman","year":"2014","journal-title":"Endocrine Abstracts"},{"key":"B270","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0301-2115(00)00370-5","article-title":"Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years","volume":"95","author":"Merviel","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0920","article-title":"Associations between human chorionic gonadotropin, maternal free thyroxine, and gestational diabetes mellitus","volume":"31","author":"Liu","year":"2021","journal-title":"Thyroid"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70264","article-title":"Determining the risk of gestational diabetes using machine learning: A study on first-trimester PAPP-A and \u03b2-hCG data","volume":"113","author":"Zorlu","year":"2025","journal-title":"J Gynaecol Obstet"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.12809\/hkmj144470","article-title":"Association between pregnancy-associated plasma protein-A levels in the first trimester and gestational diabetes mellitus in Chinese women","volume":"22","author":"Cheuk","year":"2016","journal-title":"Hong Kong Med J"},{"key":"B274","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.3390\/jcm13247725","article-title":"Early prediction of gestational diabetes mellitus and insulin therapy requirement using first-trimester PAPP-A and free \u03b2-hCG moMs levels: A retrospective case\u2013control study","volume":"13","author":"Balka\u015f","year":"2024","journal-title":"J Clin Med"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12798","article-title":"Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus","volume":"9","author":"Zhao","year":"2018","journal-title":"J Diabetes Investig"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415621","article-title":"Human placental lactogen in relation to maternal metabolic health and fetal outcomes: A systematic review and meta-analysis","volume":"23","author":"Rassie","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051595","article-title":"Increased plasma leptin in gestational diabetes","volume":"44","author":"Kautzky-Willer","year":"2001","journal-title":"Diabetologia"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2011.01.034","article-title":"Maternal serum leptin concentration in gestational diabetes","volume":"50","author":"Soheilykhah","year":"2011","journal-title":"Taiwanese J Obstetrics Gynecology"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092433","article-title":"Significance of serum-plasma leptin profile during pregnancy in gestational diabetes mellitus: A systematic review and meta-analysis","volume":"11","author":"Roca-Rodr\u00edguez","year":"2022","journal-title":"J Clin Med"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.07.016","article-title":"Elevated placental growth factor concentrations at 11\u201314 weeks of gestation to predict gestational diabetes mellitus","volume":"63","author":"Eleftheriades","year":"2014","journal-title":"Metabolism"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1159\/000441027","article-title":"First-trimester placental growth factor in screening for gestational diabetes","volume":"39","author":"Mosimann","year":"2015","journal-title":"Fetal Diagnosis Ther"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05189-5","article-title":"Angiogenic markers in gestational diabetes and their association with placental dimensions","volume":"480","author":"Madiwale","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2022.2068574","article-title":"Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus","volume":"41","author":"Kapustin","year":"2022","journal-title":"Hypertens Pregnancy"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202310_34174","article-title":"Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes","volume":"27","author":"Balka\u015f","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B285","doi-asserted-by":"publisher","first-page":"e34473","DOI":"10.1097\/MD.0000000000034473","article-title":"Meta-analysis for the relationship between circulating pregnancy-associated plasma protein A and placenta accreta","volume":"102","author":"Li","year":"2023","journal-title":"spectrum. Med (Baltimore)"},{"key":"B286","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.3390\/ijms26136187","article-title":"Combined first-trimester PAPP-A and free \u03b2-hCG levels for the early diagnosis of placenta accreta spectrum and placenta previa: A case-control study","volume":"26","author":"Belousova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1636501","article-title":"Hyperglycosylated hCG and placenta accreta spectrum","volume":"36","author":"Einerson","year":"2019","journal-title":"Am J Perinatol"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113492209","article-title":"Increased levels of cell-free human placental lactogen mRNA at 28\u201332 gestational weeks in plasma of pregnant women with placenta previa and invasive placenta","volume":"21","author":"Kawashima","year":"2014","journal-title":"Reprod Sci"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1576607","article-title":"Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no","volume":"35","author":"Li","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1159\/000492829","article-title":"Second trimester biochemical markers as possible predictors of pathological placentation: A retrospective case-control study","volume":"46","author":"Berezowsky","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5011232","article-title":"Elevated second trimester alpha-fetoprotein increases the risk of placenta accreta","volume":"50","author":"Wang","year":"2023","journal-title":"Clin. Exp. Obstet. Gynecol"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07734-5","article-title":"Relationship between maternal serum sFlt-1 level and placenta accreta spectrum disorders in the third trimester","volume":"310","author":"Zhang","year":"2024","journal-title":"Arch Gynecology Obstetrics"},{"key":"B293","doi-asserted-by":"publisher","first-page":"2183744","DOI":"10.1080\/14767058.2023.2183744","article-title":"The correlation between serum levels and placental tissue expression of PLGF and sFLT-1 and the FIGO grading of the placenta accreta","volume":"36","author":"Alessandrini","year":"2023","journal-title":"Spectr Disord J Matern Fetal Neonatal Med"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0547","article-title":"Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells","volume":"145","author":"Chen","year":"2004","journal-title":"Endocrinology"},{"key":"B295","doi-asserted-by":"publisher","first-page":"14","DOI":"10.30699\/jogcr.9.1.14","article-title":"Comparison of pregnancy-associated plasma protein-A levels in women with and without intrauterine growth restriction","volume":"9","author":"Kazemi Aski","year":"2024","journal-title":"J Obstetrics Gynecology Cancer Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1637570\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T13:46:03Z","timestamp":1758203163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1637570\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":295,"alternative-id":["10.3389\/fendo.2025.1637570"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1637570","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"1637570"}}